Skip to content

The Effect of Virtual Reality-Based Customized Exposure Training for Posttraumatic Stress Disorder

The Effect of Virtual Reality-Based Customized Exposure Training for Posttraumatic Stress Disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0009799
Enrollment
60
Registered
2024-09-26
Start date
2024-09-02
Completion date
Unknown
Last updated
2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : 1) Treatment-as-usual (TAU) CBT (n = 30): This is a general (currently practiced) CBT, and all subjects are provided with the same CBT program. 2) Customized exposure training program +

Sponsors

Hallym University Medical Center- Chuncheon
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Inclusion criteria a) 18-64 years old b) Diagnosed with anxiety disorder, trauma, and stress-related disorders (all diagnoses are based on DSM-5) c) Be able to understand the content of the consent form and ha ve verbal and cognitive abilities enough to respond to the questio nnaires and operate the VR devices/programs d) Can fully understand the detailed explanation regarding this st udy and voluntarily agree to participate in this study

Exclusion criteria

Exclusion criteria: (2) Exclusion criteria a) Those diagnosed with AXIS I other than anxiety disorder, trauma and stress-related disorder b) Those diagnosed with bipolar or psychotic disorder c) Those diagnosed with alcohol abuse and alcohol dependence d) Those who attempted suicide within 6 months from the screening date e) Those judged to have problems with EEG and electrode attachment due to scalp deformity, inflammatory reaction or other dermatological problems f) Those with a history of epileptic (epileptic) seizures or photosensitive seizures g) Those who experienced severe dizziness, eye or convulsions or temporary loss of consciousness due to flashes or patterns h) Those with organic brain abnormalities such as Parkinson's disease or cerebrovascular disease i) Those with clinically serious disorders in the cardiovascular, digestive, respiratory, endocrine, or central nervous systems j) Those with abnormal binocular vision k) In order to prevent the spread of infectious diseases (conjunctivitis), those with infectious symptoms, infections or diseases, or especially Those with infectious symptoms or diseases of the eyes, skin or scalp l) Pregnant women or breastfeeding women m) In addition to the above, those with clinically significant findings that the test director or person in charge deems inappropriate for this test based on medical judgment

Design outcomes

Primary

MeasureTime frame
Posttraumatic Diagnosis Scale;Visual Analogue Scale for Anxiety;State Anxiety Inventory-1

Secondary

MeasureTime frame
Trait Anxiety Inventory-2;The Center for Epidemiologic Studies Depression Scale;Multidimensional Assessment of Interoceptive Awareness;3D Presence/Fatigue;Electroencephalography;Functional Near-Infrared Spectroscopy;Heart Rate Variability

Countries

Korea, Republic of

Contacts

Public ContactKi Won Jang

Hallym University Medical Center- Chuncheon

e_mpathy@naver.com+82-33-240-5739

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026